231 Table 9.1 Patient Characteristics before Matching Adenomyosis (N=36) Endometriosis (N=61) Combined (N=93) Control (N=889 ) P-value BMI in kg/m2 (Median, IQR) 23.59 IQR:7.76 23.03 IQR: 6.52 23.94 IQR: 6.21 23.63 IQR: 5.61 0.2842 Infertility time in months* (Mean, SD) 37.00 IQR:30 27.50 IQR: 28 31.00 IQR: 23 28.00 IQR: 22 0.2362 Age during IVF (Mean, SD) 33.75 (± 3.61) 30.92 (± 4.03) 31.23 (± 4.11) 31.47 (± 4.47) 0.0121 Cycle length (Median, IQR) 29.00 IQR:3 28.00 IQR: 3 28.00 IQR: 2 28.00 IQR: 2 0.2602 Age at MRI 37.71 (±4.32) 32.43 (± 4.94) 34.04 (± 5.71) N/A <0.0005 Type of subfertility* Primary 18 (50.0%) a 46 (76.7%) b 65 (69.1 %) a, b 616 (69.4%) a, b <0.00053 Secondary 15 (41.7%) a 13 (21.7%) a 23 (24.5 %) a 272 (30.6%) a Unknown 3 (8.3%) 1 (1.7%) 6 (6.4%) 1 Indication** Male 11 (30.6%) a 9 (15.0%) a 12 (12.8 %) a 889 (100%) b <0.00053 Female - Ovulatory disorder - Tubal factor 5 (13.9%) a 1 (3.0%) 1 (3.0%) 10 (16.7%) a 3 (5.0%) 7 (11.7%) 9 (9.6%) a 6 (7.1%) 7 (8.2%) b Combined Male and Female factor 4 (11.1%) a 21 (35.0 %) b 24 (25.5%) a, b c Endometriosis 5 (15.2%) a 22 (36.7 %) b 36 (38.3%) b c Idiopathic 7 (21.2%) a 5 (8.3 %) b 12 (12.8%) b c Dysmenorrhoea Yes 8 (22.2%)a, b 37 (61.7%) c 48(51.1%) b, c 165 (18.6%) a <0.00053 No 15 (41.7%)a, b 13 (21.7%)c 25 (26.6%) b, c 584 (65.7%) a Unknown 13 (36.1%) 10(16.7%) 21 (22.3%) 140 (15.7%) Endometriosis Treatment prior to IVF/ICSI No treatment 15 (45.5%) 20 (33.3%) 29 (34.1%) 0 (0) Oral contraceptive pill 4 (12.1%) 12 (20.0%) 7 (8.2%) 0 (0)
RkJQdWJsaXNoZXIy MTk4NDMw